{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:55:46Z","timestamp":1762869346137,"version":"3.38.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1038\/s41443-024-00897-4","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T12:52:39Z","timestamp":1714567959000},"page":"109-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnosis and treatment of hypogonadism in men seeking to preserve fertility \u2013 what are the options?"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9939-6456","authenticated-orcid":false,"given":"Alexander William Cloberry","family":"Lockie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-4233","authenticated-orcid":false,"given":"Peter","family":"Grice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaibhav","family":"Modgil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"897_CR1","unstructured":"European Association of Urology Guidelines. Edn. presented at the EAU Annual Congress, Paris 2024. https:\/\/uroweb.org\/guidelines."},{"key":"897_CR2","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.jsxm.2017.10.067","volume":"14","author":"G Hackett","year":"2017","unstructured":"Hackett G, Kirby M, Edwards D, Jones TH, Wylie K, Ossei-Gerning N, et al. British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice. J Sex Med. 2017;14:1504\u201323.","journal-title":"J Sex Med"},{"key":"897_CR3","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1210\/jc.2009-1796","volume":"95","author":"A Tajar","year":"2010","unstructured":"Tajar A, Forti G, O\u2019Neill TW, Lee DM, Silman AJ, Finn JD, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95:1810\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.2047-2927.2012.00008.x","volume":"1","author":"RA Rey","year":"2013","unstructured":"Rey RA, Grinspon RP, Gottlieb S, Pasqualini T, Knoblovits P, Aszpis S, et al. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach. Andrology. 2013;1:3\u201316.","journal-title":"Andrology"},{"key":"897_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.metabol.2017.09.017","volume":"86","author":"GA Kanakis","year":"2018","unstructured":"Kanakis GA, Nieschlag E. Klinefelter syndrome: more than hypogonadism. Metabolism. 2018;86:135\u201344.","journal-title":"Metabolism."},{"key":"897_CR6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1210\/jc.2002-021491","volume":"88","author":"A Bojesen","year":"2003","unstructured":"Bojesen A, Juul S, Gravholt CH. Prenatal and Postnatal Prevalence of Klinefelter Syndrome: A National Registry Study. J Clin Endocrinol Metabol. 2003;88:622\u20136.","journal-title":"J Clin Endocrinol Metabol"},{"key":"897_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2021.11.016","volume":"51","author":"A Thirumalai","year":"2022","unstructured":"Thirumalai A, Anawalt BD. Epidemiology of Male Hypogonadism. Endocrinol Metab Clin North Am. 2022;51:1\u201327.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"897_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-019-0087-y","volume":"5","author":"A Salonia","year":"2019","unstructured":"Salonia A, Rastrelli G, Hackett G, Seminara SB, Huhtaniemi IT, Rey RA, et al. Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers. 2019;5:38.","journal-title":"Nat Rev Dis Primers"},{"key":"897_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.ijir.3901365","volume":"18","author":"A Seftel","year":"2006","unstructured":"Seftel A. Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis. Int J Impot Res. 2006;18:223\u20138.","journal-title":"Int J Impot Res"},{"key":"897_CR10","first-page":"179","volume":"16","author":"M Fromantin","year":"1973","unstructured":"Fromantin M, Gineste J, Didier A, Rouvier J. Impuberism and hypogonadism at induction into military service. Statistical study. Probl Actuels Endocrinol Nutr. 1973;16:179\u201399.","journal-title":"Probl Actuels Endocrinol Nutr"},{"key":"897_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrendo.2015.112","volume":"11","author":"U Boehm","year":"2015","unstructured":"Boehm U, Bouloux PM, Dattani MT, de Roux N, Dod\u00e9 C, Dunkel L, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism\u2013pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547\u201364.","journal-title":"Nat Rev Endocrinol"},{"key":"897_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ucl.2016.01.001","volume":"43","author":"PF Corradi","year":"2016","unstructured":"Corradi PF, Corradi RB, Greene LW. Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male. Urol Clin North Am. 2016;43:151\u201362.","journal-title":"Urol Clin North Am"},{"key":"897_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00427-006-0125-0","volume":"217","author":"B Ayari","year":"2007","unstructured":"Ayari B, Soussi-Yanicostas N. FGFR1 and anosmin-1 underlying genetically distinct forms of Kallmann syndrome are co-expressed and interact in olfactory bulbs. Dev Genes Evol. 2007;217:169\u201375.","journal-title":"Dev Genes Evol"},{"key":"897_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/EJE-17-0065","volume":"178","author":"M Bonomi","year":"2018","unstructured":"Bonomi M, Vezzoli V, Krausz C, Guizzardi F, Vezzani S, Simoni M, et al. Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH). Eur J Endocrinol. 2018;178:23\u201332.","journal-title":"Eur J Endocrinol"},{"key":"897_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/353529a0","volume":"353","author":"B Franco","year":"1991","unstructured":"Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, et al. A gene deleted in Kallmann\u2019s syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature. 1991;353:529\u201336.","journal-title":"Nature"},{"key":"897_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1210\/er.2018-00116","volume":"40","author":"J Young","year":"2019","unstructured":"Young J, Xu C, Papadakis GE, Acierno JS, Maione L, Hietam\u00e4ki J, et al. Clinical Management of Congenital Hypogonadotropic Hypogonadism. Endocr Rev. 2019;40:669\u2013710.","journal-title":"Endocr Rev"},{"key":"897_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/pbc.21498","volume":"51","author":"A Guyot-Goubin","year":"2008","unstructured":"Guyot-Goubin A, Donadieu J, Barkaoui M, Bellec S, Thomas C, Clavel J. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer. 2008;51:71\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"897_CR18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","volume":"86","author":"SM Harman","year":"2001","unstructured":"Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR19","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1210\/jc.2007-1972","volume":"93","author":"FC Wu","year":"2008","unstructured":"Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O\u2019Neill TW, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93:2737\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR20","doi-asserted-by":"publisher","first-page":"e12901","DOI":"10.1111\/ijcp.12901","volume":"71","author":"G Hackett","year":"2017","unstructured":"Hackett G, Kirby M, Edwards D, Jones TH, Rees J, Muneer A. UK policy statements on testosterone deficiency. Int J Clin Pract. 2017;71:e12901.","journal-title":"Int J Clin Pract"},{"key":"897_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0911101","volume":"363","author":"FC Wu","year":"2010","unstructured":"Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123\u201335.","journal-title":"N Engl J Med"},{"key":"897_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","volume":"80","author":"A Salonia","year":"2021","unstructured":"Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction. Eur Urol. 2021;80:333\u201357.","journal-title":"Eur Urol"},{"key":"897_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/13685538.2022.2046727","volume":"25","author":"P Facondo","year":"2022","unstructured":"Facondo P, Di Lodovico E, Pezzaioli LC, Cappelli C, Ferlin A, Delbarba A. Usefulness of routine assessment of free testosterone for the diagnosis of functional male hypogonadism. Aging Male. 2022;25:65\u201371.","journal-title":"Aging Male"},{"key":"897_CR24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1210\/jcem-71-4-929","volume":"71","author":"B Zumoff","year":"1990","unstructured":"Zumoff B, Strain GW, Miller LK, Rosner W, Senie R, Seres DS, et al. Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab. 1990;71:929\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR25","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1742-1241.2010.02355.x","volume":"64","author":"P Dandona","year":"2010","unstructured":"Dandona P, Rosenberg MT. A practical guide to male hypogonadism in the primary care setting. Int J Clin Pract. 2010;64:682\u201396.","journal-title":"Int J Clin Pract"},{"key":"897_CR26","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1111\/j.1743-6109.2011.02497.x","volume":"8","author":"VA Giagulli","year":"2011","unstructured":"Giagulli VA, Triggiani V, Carbone MD, Corona G, Tafaro E, Licchelli B, et al. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism. J Sex Med. 2011;8:3471\u20138.","journal-title":"J Sex Med"},{"key":"897_CR27","first-page":"407","volume":"82","author":"S Bhasin","year":"1997","unstructured":"Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab. 1997;82:407\u201313.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.juro.2015.10.083","volume":"195","author":"G Brock","year":"2016","unstructured":"Brock G, Heiselman D, Maggi M, Kim SW, Rodr\u00edguez Vallejo JM, Behre HM, et al. Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study. J Urol. 2016;195:699\u2013705.","journal-title":"J Urol"},{"key":"897_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms22010021","volume":"22","author":"V Ide","year":"2020","unstructured":"Ide V, Vanderschueren D, Antonio L. Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy. Int J Mol Sci. 2020;22:21.","journal-title":"Int J Mol Sci"},{"key":"897_CR30","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s40618-016-0480-2","volume":"39","author":"G Corona","year":"2016","unstructured":"Corona G, Giagulli VA, Maseroli E, Vignozzi L, Aversa A, Zitzmann M, et al. Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest. 2016;39:967\u201381.","journal-title":"J Endocrinol Invest"},{"key":"897_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1210\/er.2017-00234","volume":"39","author":"PJ Snyder","year":"2018","unstructured":"Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, et al. Lessons From the Testosterone Trials. Endocr Rev. 2018;39:369\u201386.","journal-title":"Endocr Rev"},{"key":"897_CR32","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1210\/jc.2007-1692","volume":"93","author":"AD Coviello","year":"2008","unstructured":"Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab. 2008;93:914\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR33","doi-asserted-by":"publisher","first-page":"e2348692","DOI":"10.1001\/jamanetworkopen.2023.48692","volume":"6","author":"S Bhasin","year":"2023","unstructured":"Bhasin S, Travison TG, Pencina KM, O\u2019Leary M, Cunningham GR, Lincoff AM, et al. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023;6:e2348692.","journal-title":"JAMA Netw Open"},{"key":"897_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2215025","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389:107\u201317.","journal-title":"N Engl J Med"},{"key":"897_CR35","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2018-00229","volume":"103","author":"S Bhasin","year":"2018","unstructured":"Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1715\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1056\/NEJMra022251","volume":"350","author":"EL Rhoden","year":"2004","unstructured":"Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med. 2004;350:482\u201392.","journal-title":"N Engl J Med"},{"key":"897_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/JU.0000000000001078","volume":"204","author":"R Ramasamy","year":"2020","unstructured":"Ramasamy R, Masterson TA, Best JC, Bitran J, Ibrahim E, Molina M, et al. Effect of Natesto on Reproductive Hormones, Semen Parameters and Hypogonadal Symptoms: A Single Center, Open Label, Single Arm Trial. J Urol. 2020;204:557\u201363.","journal-title":"J Urol"},{"key":"897_CR38","doi-asserted-by":"publisher","first-page":"e14453","DOI":"10.1111\/and.14453","volume":"54","author":"PK Kavoussi","year":"2022","unstructured":"Kavoussi PK, Machen GL, Chen SH, Gilkey MS, Chen J, Hamzeh Y, et al. Direct conversion from long-acting testosterone replacement therapy to Natesto allows for spermatogenesis resumption: Proof of concept. Andrologia. 2022;54:e14453.","journal-title":"Andrologia."},{"key":"897_CR39","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.sxmr.2018.10.001","volume":"7","author":"KM Wheeler","year":"2019","unstructured":"Wheeler KM, Sharma D, Kavoussi PK, Smith RP, Costabile R. Clomiphene Citrate for the Treatment of Hypogonadism. Sex Med Rev. 2019;7:272\u20136.","journal-title":"Sex Med Rev"},{"key":"897_CR40","doi-asserted-by":"publisher","first-page":"2014.e11","DOI":"10.1016\/j.fertnstert.2008.03.036","volume":"90","author":"FF Pasqualotto","year":"2008","unstructured":"Pasqualotto FF, Fonseca GP, Pasqualotto EB. Azoospermia after treatment with clomiphene citrate in patients with oligospermia. Fertil Steril. 2008;90:2014.e11\u20132.","journal-title":"Fertil Steril"},{"key":"897_CR41","first-page":"187","volume":"40","author":"GJ Matthews","year":"1995","unstructured":"Matthews GJ, Goldstein M, Henry JM, Schlegel PN. Nonbacterial pyospermia: a consequence of clomiphene citrate therapy. Int J Fertil Menopausal Stud. 1995;40:187\u201391.","journal-title":"Int J Fertil Menopausal Stud"},{"key":"897_CR42","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/andr.13146","volume":"10","author":"M Huijben","year":"2022","unstructured":"Huijben M, Lock M, de Kemp VF, de Kort LMO, van Breda HMK. Clomiphene citrate for men with hypogonadism: a systematic review and meta-analysis. Andrology. 2022;10:451\u201369.","journal-title":"Andrology"},{"key":"897_CR43","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/andr.13388","volume":"11","author":"M Huijben","year":"2023","unstructured":"Huijben M, Huijsmans RLN, Lock M, de Kemp VF, de Kort LMO, van Breda J. Clomiphene citrate for male infertility: A systematic review and meta-analysis. Andrology. 2023;11:987\u201396.","journal-title":"Andrology"},{"key":"897_CR44","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.juro.2016.10.068","volume":"197","author":"KM Wheeler","year":"2017","unstructured":"Wheeler KM, Smith RP, Kumar RA, Setia S, Costabile RA, Kavoussi PK. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study. J Urol. 2017;197:1127\u201331.","journal-title":"J Urol"},{"key":"897_CR45","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1002\/edm2.416","volume":"6","author":"M Huijben","year":"2023","unstructured":"Huijben M, Lock M, de Kemp VF, Beck JJH, De Kort LMO, van Breda HMK. Clomiphene citrate: A potential alternative for testosterone therapy in hypogonadal males. Endocrinol Diabetes Metab. 2023;6:e416.","journal-title":"Endocrinol Diabetes Metab"},{"key":"897_CR46","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.2174\/1381612826666200523175806","volume":"27","author":"L Boeri","year":"2021","unstructured":"Boeri L, Capogrosso P, Salonia A. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism. Curr Pharm Des. 2021;27:2775\u201383.","journal-title":"Curr Pharm Des"},{"key":"897_CR47","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/andr.262","volume":"2","author":"G Rastrelli","year":"2014","unstructured":"Rastrelli G, Corona G, Mannucci E, Maggi M. Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology. 2014;2:794\u2013808.","journal-title":"Andrology"},{"key":"897_CR48","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1210\/jc.2018-02697","volume":"104","author":"AA Dwyer","year":"2019","unstructured":"Dwyer AA, Chavan NR, Lewkowitz-Shpuntoff H, Plummer L, Hayes FJ, Seminara SB, et al. Functional Hypogonadotropic Hypogonadism in Men: Underlying Neuroendocrine Mechanisms and Natural History. J Clin Endocrinol Metab. 2019;104:3403\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR49","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1210\/jcem-66-6-1144","volume":"66","author":"AS Burris","year":"1988","unstructured":"Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab. 1988;66:1144\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR50","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJM198509123131102","volume":"313","author":"DM Finkel","year":"1985","unstructured":"Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med. 1985;313:651\u20135.","journal-title":"N Engl J Med"},{"key":"897_CR51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.beem.2014.10.005","volume":"29","author":"AA Dwyer","year":"2015","unstructured":"Dwyer AA, Raivio T, Pitteloud N. Gonadotrophin replacement for induction of fertility in hypogonadal men. Best Pract Res Clin Endocrinol Metab. 2015;29:91\u2013103.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"897_CR52","doi-asserted-by":"publisher","first-page":"E1790","DOI":"10.1210\/jc.2013-2518","volume":"98","author":"AA Dwyer","year":"2013","unstructured":"Dwyer AA, Sykiotis GP, Hayes FJ, Boepple PA, Lee H, Loughlin KR, et al. Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2013;98:E1790\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1210\/er.2008-0016","volume":"30","author":"RJ Santen","year":"2009","unstructured":"Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A. History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target. Endocrine Rev. 2009;30:343\u201375.","journal-title":"Endocrine Rev"},{"key":"897_CR54","first-page":"3027","volume":"85","author":"FJ Hayes","year":"2000","unstructured":"Hayes FJ, Seminara SB, Decruz S, Boepple PA, Crowley WF Jr. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab. 2000;85:3027\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR55","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1210\/jc.2003-031467","volume":"89","author":"BZ Leder","year":"2004","unstructured":"Leder BZ, Rohrer JL, Rubin SD, Gallo J, Longcope C. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. J Clin Endocrinol Metab. 2004;89:1174\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/andr.12126","volume":"4","author":"JP Dias","year":"2016","unstructured":"Dias JP, Melvin D, Simonsick EM, Carlson O, Shardell MD, Ferrucci L, et al. Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial. Andrology. 2016;4:33\u201340.","journal-title":"Andrology"},{"key":"897_CR57","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1210\/jc.2005-0982","volume":"90","author":"GG T\u2019Sjoen","year":"2005","unstructured":"T\u2019Sjoen GG, Giagulli VA, Delva H, Crabbe P, De Bacquer D, Kaufman JM. Comparative assessment in young and elderly men of the gonadotropin response to aromatase inhibition. J Clin Endocrinol Metab. 2005;90:5717\u201322.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR58","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1111\/andr.12725","volume":"8","author":"M Awouters","year":"2020","unstructured":"Awouters M, Vanderschueren D, Antonio L. Aromatase inhibitors and selective estrogen receptor modulators: Unconventional therapies for functional hypogonadism? Andrology. 2020;8:1590\u20137.","journal-title":"Andrology"},{"key":"897_CR59","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1210\/jc.2009-0739","volume":"94","author":"SA Burnett-Bowie","year":"2009","unstructured":"Burnett-Bowie SA, McKay EA, Lee H, Leder BZ. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab. 2009;94:4785\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR60","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1530\/EJE-12-0890","volume":"168","author":"EM Camacho","year":"2013","unstructured":"Camacho EM, Huhtaniemi IT, O\u2019Neill TW, Finn JD, Pye SR, Lee DM, et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol. 2013;168:445\u201355.","journal-title":"Eur J Endocrinol"},{"key":"897_CR61","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1210\/jc.2011-0118","volume":"96","author":"M Grossmann","year":"2011","unstructured":"Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab. 2011;96:2341\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.01.038","volume":"149","author":"M Bawor","year":"2015","unstructured":"Bawor M, Bami H, Dennis BB, Plater C, Worster A, Varenbut M, et al. Testosterone suppression in opioid users: a systematic review and meta-analysis. Drug Alcohol Depend. 2015;149:1\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"897_CR63","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1210\/jc.2016-3580","volume":"102","author":"M Grossmann","year":"2017","unstructured":"Grossmann M, Matsumoto AM. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. J Clin Endocrinol Metabol. 2017;102:1067\u201375.","journal-title":"J Clin Endocrinol Metabol"},{"key":"897_CR64","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1210\/jc.2007-2177","volume":"93","author":"M Grossmann","year":"2008","unstructured":"Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008;93:1834\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"897_CR65","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.eururo.2021.08.014","volume":"80","author":"S Minhas","year":"2021","unstructured":"Minhas S, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male Infertility. Eur Urol. 2021;80:603\u201320.","journal-title":"Eur Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00897-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00897-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00897-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T13:19:00Z","timestamp":1740489540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-024-00897-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1038\/s41443-024-00897-4","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"type":"print","value":"0955-9930"},{"type":"electronic","value":"1476-5489"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"2 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}